MARS Global: The Scientific Partner Trusted by Global Pharma

Specialist Clinical Research Company • Biostatistics  ·  Evidence Generation  ·  Medical Writing

The Scientific Safeguard for Global Clinical Excellence.

Precision Biostatistics. Decision-Grade Evidence. Expert Insourcing.

We protect the integrity of your clinical legacy through elite methodological rigour and a 100% Q1-quartile publication success rate.

21+Countries of Global Footprint
0.9%Document Error Margin
100%Q1 Peer-Review Success Rate
15+Years Specialised CRO Leadership
160+Peer-Reviewed Publications
$4M+Secured in Grants
All Pharma Clinical Research Health Systems Academic Publishing Government

Beyond Outsourcing: This is Expert Insourcing.

In high-stakes clinical research, a single methodological oversight can jeopardise years of development. MARS Global acts as your Scientific Safeguard. We do not operate as a traditional "outsourced" vendor. Instead, we insource PhD-level expertise directly into your internal workflow, providing the safety net of rigour that allows your Medical Affairs and Research teams to focus on innovation while we secure the evidence. From protocol audits to Q1-standard manuscripts, we ensure your science is unassailable.

01

Precision Biostatistics

From protocol design through to final regulatory submission, our biostatisticians are embedded directly in your workflow. Every analysis is built to withstand the scrutiny of top-tier journals and global health authorities.

Sample Size RCT Analysis Survival Analysis Mixed Models Meta-Analysis R & SAS
Discuss Your Study →
02

Decision-Grade Evidence

Market access requires evidence that moves decision-makers. We design and deliver real-world evidence strategies, HEOR frameworks, and outcomes research built to convert data into market advantage globally.

Real-World Evidence HEOR Outcomes Research E2M Framework Market Access
Explore the E2M Framework →
03

Expert Medical Writing

Scientific accuracy is not negotiable. MARS Global produces manuscripts, regulatory submissions, and clinical study reports to Q1-journal standard, because your science deserves to be read, cited, and acted on.

Manuscripts CSRs Systematic Reviews Regulatory Dossiers Q1 Journals
Start a Project →

Published Research for Partners.

Our authority isn't claimed, it is peer-reviewed. MARS Global maintains a dedicated internal research hub that secures publications in top-tier Q1 journals. We bring this same academic intensity to every partner project, ensuring your data isn't just processed, it's positioned for global impact.

Global Pharma & Partners Academic Alliances Capacity Building In the Press
IQVIA KSA & Abbott KSA

Transforming Respiratory Tract Infection Diagnosis in the Kingdom of Saudi Arabia Through Point-of-Care Testing: A White Paper for Policy Makers

ScienceDirect · Journal of Clinical Virology View Publication →
IQVIA KSA & Saudi CDC

Vaccine Hesitancy in Saudi Arabia: A Cross-Sectional Study

MDPI · Tropical Medicine and Infectious Disease View Publication →
IQVIA UAE & Abbott UAE

Recommendations on Rapid Diagnostic Point-of-Care Molecular Tests for Respiratory Infections in the United Arab Emirates

Open Respiratory Medicine Journal View Publication →
Orchidia Pharmaceutical

Efficacy and Safety of Preservative-Free Anti-Glaucomatous Eye Drops (Dorzolamide/Timolol) in Ocular Hypertension and/or Glaucoma

Springer · International Ophthalmology View Publication →
Danone

A Noninvasive Approach to Assess the Prevalence of and Factors Associated With Anemia Risk in Malaysian Children Under Three Years of Age: Cross-Sectional Study

JMIR Pediatrics · 2025 View Publication →
Novartis

Effectiveness of Secukinumab in Patients with Psoriasis and Psoriatic Arthritis in a Saudi Real-World Setting

PubMed · NCBI View Publication →
NMC Royal Abu Dhabi

Reduced ADAMTS13 Activity in Correlation with Pathophysiology, Severity, and Outcome of COVID-19: A Retrospective Observational Study

ScienceDirect · International Journal of Infectious Diseases View Publication →
NMC Royal Abu Dhabi

Vitamin D Status in Relation to the Clinical Outcome of Hospitalized COVID-19 Patients

Frontiers in Medicine · 2022 View Publication →
NMC Royal Abu Dhabi

Interleukin-6 and the Determinants of Severe COVID-19: A Retrospective Cohort Study

LWW Medicine Journal · 2023 View Publication →

What Our Partners Say.

"

Consistently impressed with your experience, diligence, efficiency, and ability to get things done in a perfect way.

Yasser Suliman

Engagement Manager, Primary Intelligence
IQVIA KSA

"

Always available once requested 24/7. A scientific partner who never compromises on quality, regardless of the complexity or urgency of the work.

Dr. Wael Hafez

Internal Medicine Consultant
NMC Royal Hospital Abu Dhabi

"

A rare combination of intellectual versatility, methodological rigour, and an ability to translate complex ideas into actionable insights. Anyone looking for a researcher who is proactive, skilled, and genuinely committed to advancing knowledge would be fortunate to work with this team.

Nasser Al Qhtani

Medical Lead Immunology, Medical Affairs
Healthcare Strategy and Innovation

Research Grants Secured.

MARS Global has successfully secured over $4M in competitive grant funding from global institutions, a testament to the scientific credibility and methodological strength we bring to every research programme.

STDF: Science, Technology & Innovation Funding Authority

Safety and Efficacy of Different Therapeutic Regimens in Egyptian Adults with Moderate COVID-19 Infection (EVEREST): A Real-World Retrospective Study

APC Support · Oct 2025
Abu Dhabi Healthcare Research & Innovation Grant

Mapping Sepsis Progression for Precision Medicine Through Temporal Omics: A Lifespan Approach with AI-Driven Outcome Prediction and Tracking Through Novel Biomarking

Nov 2024
Global Bridges at Mayo Clinic

Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis

Oct 2024
Pfizer Independent Medical Education Grant

Enhancing Patient Safety Through Healthcare Provider Education on Pharmacovigilance in Kenya, delivered in partnership with Clinical Research Key (CRO)

Sep 2023
Pfizer Global

Invasive Fungal Infections Competitive Grant Program, delivered in partnership with Clinical Research Key (CRO)

Sep 2022
Pfizer Global & British Medical Journal

Developing Clinical Research and Publication Skills: Competitive Grant Program Using Expert Review Panel

Dec 2021
Science, Technology, and Social Sciences Conference 2021

Best Paper Presenter Award in Science, Technology, and Social Sciences

Dec 2021
Special Projects of the Central Government, China (No. 2021L3018)

Digital Health Literacy for COVID-19 Vaccination and Intention to be Immunized: A Cross-Sectional Multi-Country Study Among the General Adult Population

Sep 2021
Fujian Provincial Department of Science and Technology (No. 2020Y0005)

Perceived COVID-19 Vaccine Effectiveness, Acceptance, and Drivers of Vaccination Decision-Making Among the General Adult Population: A Global Survey of 20 Countries

Feb 2021

Science That Stands Alone.

Beyond client-led projects, MARS Global drives its own independent research programme, publishing across clinical medicine, epidemiology, bioinformatics, and public health in globally recognised journals.

2026 · Systematic Review & Meta-Analysis

Is Anybody Out There? Tackling Intimate Partner Violence as a Hidden Pandemic During COVID Times and Beyond: Factors, Impact, and Recommendations

Archives of Women's Mental Health 29 (1), 20 View Publication →
2025 · Real-World Study

Safety and Efficacy of Different Therapeutic Regimens in Egyptian Adults with Moderate COVID-19 Infection (EVEREST): A Real-World Retrospective Study

Scientific Reports 15 (1), 36477 View Publication →
2025 · Systematic Review & Meta-Analysis

The Effectiveness of Mobile Health Applications on the Quality of Life of Hypertension Patients: A Systematic Review and Meta-Analysis

Health Policy and Technology 14 (5), 101064 View Publication →
2025 · Bioinformatics

Evaluating Gene Expression Patterns for NF-κB1, TNF, and VEGF A & VEGF B in a Mouse Model of SARS-CoV-2 Infection

Medicine in Microecology 24, 100124 View Publication →
2025 · Systematic Review & Meta-Analysis

The Accuracy of Artificial Intelligence in the Diagnosis of Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis

Current Problems in Surgery 66, 101743 View Publication →
2025 · Network Meta-Analysis

Ciprofloxacin Resistance Patterns in Pediatric Lower Respiratory Tract Infections in Arabian Countries: A Systematic Review and Network Meta-Analysis

Abstracts from the Globesync Community Research & Sustainability Conference View Publication →
2025 · Bioinformatics

Mapping the Key Players in Kawasaki Disease: Role of Inflammatory Genes and Protein–Protein Interactions

Informatics in Medicine Unlocked 56, 101645 View Publication →
2024 · Multicentre Study

Lumbar Spine Coronal Balance Parameters as a Predictor of Rehabilitation Management Outcomes in Patients with Radiculopathy Due to Lumbar Disc Herniation: A Multicentre Study

Heliyon 10 (23) View Publication →
2024 · Bioinformatics

Advancing Temporal Sepsis Biomarking: Covariate Vascular Endothelial Growth Factor A and B Gene Expression Profiling in a Murine Model of SARS-CoV Infection

Informatics in Medicine Unlocked 47, 101474 View Publication →
2024 · Epidemiology

Estimating the Prevalence of Non-Communicable Diseases and Adherence to Dietary Habits and Physical Activity Among Healthcare Professionals in the Middle East and North Africa

Journal of Current Health Sciences 4 (2), 67–78 View Publication →
2024 · Systematic Review & Meta-Analysis

Closed (Veress Needle) vs. Open (Hasson Cannula) Approach to Creating Pneumoperitoneum in Laparoscopic Cholecystectomy in Patients with No Previous Abdominal Surgery: A Systematic Review and Meta-Analysis

Current Problems in Surgery 61 (12), 101634 View Publication →
Pharmacoepidemiology

Efficacy of Restricted Prescribing Protocol of Sacubitril Valsartan in Heart Failure with Reduced Ejection Fraction (HFrEF) in a Tertiary Centre in Saudi Arabia

Pharmacoepidemiology and Drug Safety 32, 327 View Publication →

Secure Your Scientific Legacy.

Operating at the intersection of academic rigour and real-world application, MARS Global is the trusted partner for organisations that refuse to settle for "good enough" data.

>